292 related articles for article (PubMed ID: 17178865)
1. RhoA mediates cyclooxygenase-2 signaling to disrupt the formation of adherens junctions and increase cell motility.
Chang YW; Marlin JW; Chance TW; Jakobi R
Cancer Res; 2006 Dec; 66(24):11700-8. PubMed ID: 17178865
[TBL] [Abstract][Full Text] [Related]
2. Rho and Rho-kinase (ROCK) signaling in adherens and gap junction assembly in corneal epithelium.
Anderson SC; Stone C; Tkach L; SundarRaj N
Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):978-86. PubMed ID: 11923237
[TBL] [Abstract][Full Text] [Related]
3. PRL tyrosine phosphatases regulate rho family GTPases to promote invasion and motility.
Fiordalisi JJ; Keller PJ; Cox AD
Cancer Res; 2006 Mar; 66(6):3153-61. PubMed ID: 16540666
[TBL] [Abstract][Full Text] [Related]
4. Cell adhesion molecule L1 disrupts E-cadherin-containing adherens junctions and increases scattering and motility of MCF7 breast carcinoma cells.
Shtutman M; Levina E; Ohouo P; Baig M; Roninson IB
Cancer Res; 2006 Dec; 66(23):11370-80. PubMed ID: 17145883
[TBL] [Abstract][Full Text] [Related]
5. Regulation of Sertoli-germ cell adherens junction dynamics in the testis via the nitric oxide synthase (NOS)/cGMP/protein kinase G (PRKG)/beta-catenin (CATNB) signaling pathway: an in vitro and in vivo study.
Lee NP; Mruk DD; Wong CH; Cheng CY
Biol Reprod; 2005 Sep; 73(3):458-71. PubMed ID: 15858215
[TBL] [Abstract][Full Text] [Related]
6. ROCK and Dia have opposing effects on adherens junctions downstream of Rho.
Sahai E; Marshall CJ
Nat Cell Biol; 2002 Jun; 4(6):408-15. PubMed ID: 11992112
[TBL] [Abstract][Full Text] [Related]
7. Mammalian diaphanous-related formin Dia1 controls the organization of E-cadherin-mediated cell-cell junctions.
Carramusa L; Ballestrem C; Zilberman Y; Bershadsky AD
J Cell Sci; 2007 Nov; 120(Pt 21):3870-82. PubMed ID: 17940061
[TBL] [Abstract][Full Text] [Related]
8. Anti-RhoA and anti-RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivo.
Pillé JY; Denoyelle C; Varet J; Bertrand JR; Soria J; Opolon P; Lu H; Pritchard LL; Vannier JP; Malvy C; Soria C; Li H
Mol Ther; 2005 Feb; 11(2):267-74. PubMed ID: 15668138
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of EPHA2 receptor destabilizes adherens junctions via a RhoA-dependent mechanism.
Fang WB; Ireton RC; Zhuang G; Takahashi T; Reynolds A; Chen J
J Cell Sci; 2008 Feb; 121(Pt 3):358-68. PubMed ID: 18198190
[TBL] [Abstract][Full Text] [Related]
10. Macrophage activation increases the invasive properties of hepatoma cells by destabilization of the adherens junction.
Lin CY; Lin CJ; Chen KH; Wu JC; Huang SH; Wang SM
FEBS Lett; 2006 May; 580(13):3042-50. PubMed ID: 16678166
[TBL] [Abstract][Full Text] [Related]
11. Implication of metastasis suppressor NM23-H1 in maintaining adherens junctions and limiting the invasive potential of human cancer cells.
Boissan M; De Wever O; Lizarraga F; Wendum D; Poincloux R; Chignard N; Desbois-Mouthon C; Dufour S; Nawrocki-Raby B; Birembaut P; Bracke M; Chavrier P; Gespach C; Lacombe ML
Cancer Res; 2010 Oct; 70(19):7710-22. PubMed ID: 20841469
[TBL] [Abstract][Full Text] [Related]
12. Bombesin stimulates invasion and migration of Isreco1 colon carcinoma cells in a Rho-dependent manner.
Saurin JC; Fallavier M; Sordat B; Gevrey JC; Chayvialle JA; Abello J
Cancer Res; 2002 Aug; 62(16):4829-35. PubMed ID: 12183443
[TBL] [Abstract][Full Text] [Related]
13. RhoA/ROCK and Cdc42 regulate cell-cell contact and N-cadherin protein level during neurodetermination of P19 embryonal stem cells.
Laplante I; Béliveau R; Paquin J
J Neurobiol; 2004 Sep; 60(3):289-307. PubMed ID: 15281068
[TBL] [Abstract][Full Text] [Related]
14. The morphogenic function of E-cadherin-mediated adherens junctions in epithelial ovarian carcinoma formation and progression.
Wu C; Cipollone J; Maines-Bandiera S; Tan C; Karsan A; Auersperg N; Roskelley CD
Differentiation; 2008 Feb; 76(2):193-205. PubMed ID: 17608733
[TBL] [Abstract][Full Text] [Related]
15. Involvement of Rac and Rho signaling in cancer cell motility in 3D substrates.
Yamazaki D; Kurisu S; Takenawa T
Oncogene; 2009 Apr; 28(13):1570-83. PubMed ID: 19234490
[TBL] [Abstract][Full Text] [Related]
16. E-cadherin regulates the association between beta-catenin and actinin-4.
Hayashida Y; Honda K; Idogawa M; Ino Y; Ono M; Tsuchida A; Aoki T; Hirohashi S; Yamada T
Cancer Res; 2005 Oct; 65(19):8836-45. PubMed ID: 16204054
[TBL] [Abstract][Full Text] [Related]
17. Neuropeptide-stimulated cell migration in prostate cancer cells is mediated by RhoA kinase signaling and inhibited by neutral endopeptidase.
Zheng R; Iwase A; Shen R; Goodman OB; Sugimoto N; Takuwa Y; Lerner DJ; Nanus DM
Oncogene; 2006 Sep; 25(44):5942-52. PubMed ID: 16652149
[TBL] [Abstract][Full Text] [Related]
18. RRIG1 mediates effects of retinoic acid receptor beta2 on tumor cell growth and gene expression through binding to and inhibition of RhoA.
Liang ZD; Lippman SM; Wu TT; Lotan R; Xu XC
Cancer Res; 2006 Jul; 66(14):7111-8. PubMed ID: 16849557
[TBL] [Abstract][Full Text] [Related]
19. Presenilin 1/gamma-secretase is associated with cadmium-induced E-cadherin cleavage and COX-2 gene expression in T47D breast cancer cells.
Park CS; Kim OS; Yun SM; Jo SA; Jo I; Koh YH
Toxicol Sci; 2008 Dec; 106(2):413-22. PubMed ID: 18791180
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of rho-associated kinase signaling prevents breast cancer metastasis to human bone.
Liu S; Goldstein RH; Scepansky EM; Rosenblatt M
Cancer Res; 2009 Nov; 69(22):8742-51. PubMed ID: 19887617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
